Chemoinformaics analysis of 2-Cyclopentene-1-tridecanoic acid
Molecular Weight | 280.452 | nRot | 13 |
Heavy Atom Molecular Weight | 248.196 | nRig | 6 |
Exact Molecular Weight | 280.24 | nRing | 1 |
Solubility: LogS | -5.298 | nHRing | 0 |
Solubility: LogP | 6.945 | No. of Aliphatic Rings | 1 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 53.0014 |
nHD | 1 | BPOL | 32.9706 |
QED | 0.346 |
Synth | 2.704 |
Natural Product Likeliness | 1.128 |
NR-PPAR-gamma | 0.977 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.002 |
Pgp-sub | 0 |
HIA | 0.01 |
CACO-2 | -5.089 |
MDCK | 0.000029 |
BBB | 0.116 |
PPB | 0.992853 |
VDSS | 0.726 |
FU | 0.0147902 |
CYP1A2-inh | 0.252 |
CYP1A2-sub | 0.209 |
CYP2c19-inh | 0.153 |
CYP2c19-sub | 0.096 |
CYP2c9-inh | 0.285 |
CYP2c9-sub | 0.985 |
CYP2d6-inh | 0.01 |
CYP2d6-sub | 0.128 |
CYP3a4-inh | 0.144 |
CYP3a4-sub | 0.029 |
CL | 1.714 |
T12 | 0.626 |
hERG | 0.023 |
Ames | 0.006 |
ROA | 0.014 |
SkinSen | 0.946 |
Carcinogencity | 0.057 |
EI | 0.983 |
Respiratory | 0.887 |
NR-Aromatase | 0.102 |
Antiviral | Yes |
Prediction | 0.623592 |